Answer of the Canadian National Group
|
|
- Wesley Wheeler
- 5 years ago
- Views:
Transcription
1 AIPPI INTERNATIONAL ASSOCIATION FOR THE PROTECTION OF INTELLECTUAL PROPERTY SPECIAL COMMITTEE Q94 QUESTIONNAIRE NO. 4 on the IMPLEMENTATION OF PARAGRAPH 6 OF THE DOHA DECLARATION ON TRIPS AND PUBLIC HEALTH Answer of the Canadian National Group 1
2 1. QUESTION 1 Steps to implement the WTO decision In the preamble to the WTO General Council decision, reference is made to the instruction of the Ministerial Conference in Doha, 2001 that an expeditious solution is to be found for the difficulties in some WTO member countries in regard to access to pharmaceutical products. 1.1 Are you aware of any actual or impending legislative amendments in your country, including, statements of intention to introduce amendments, consultation processes with a view to legislative amendments, proposals for new or amended legislation already enacted legislation with a view to implementing any or all of the features of the WTO Council decision? X Yes If yes, please provide details such as Government Act, Regulation, Proclamation or Bill no. Proposal or Policy Paper details Website information for text Other details The following federal Canadian legislation pertains to Canada s implementation of the WTO Council decision August 30, 2003: Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act (The Jean Chrétien Pledge to Africa), 3 rd Sess., 37 th Parl., 2004, (assented to 14 May 2004), S.C. 2004, c. 23. [the Act ]. The purpose of the Act is to amend the Patent Act, R.S.C. 1985, c. P-4 and the Food and Drugs Act, R.S.C. 1985, c. F-27 to allow the Commissioner of Patents to authorize the production, sale and export of patented medicines in accordance with the WTO Council decision. Website Information for text: pdf. version available at nt/c-9_4.pdf Information on Bill C-9 at 2
3 The Act has been enacted but has not yet come into force (as of November 8, 2004). Coming into force will require a proclamation by the Government of Canada. On October 2, 2004 proposed regulations under the amendments to the Patent Act and Food and Drugs Act were published. There is a 75-day period to make representations regarding the regulations; this ends December 17, The representations will be considered and a final version of the regulations will be published, with the Act being proclaimed into force a short time later. Presently, Canadian government officials have indicated that they anticipate the Act being proclaimed in the February/March 2005 time frame. 1.2 Has your country made any changes to your laws to provide for importation licences in respect of pharmaceutical products? If so, please provide details. Yes Act / Regulation / Proclamation no. Website information for text Other details Canada has not made any changes to provide for importation licences. Regarding importation, Canada has opted out of the system set out in the WTO General Council decision of August 30, Has your country made any changes to your laws to provide for exportation licences in respect of pharmaceutical products? If so, please provide details. X Yes Act / Regulation / Proclamation no. Website information for text Other details Bill C-9, which is referenced in question 1.1 above, contains provisions that permit the Commissioner of Patents to authorize production of patented medicines for sale and export. Any such export licences will be subject to the conditions as set out in s. 1 of the Act. 3
4 2. QUESTION 2 Identification of eligible importing countries Clause 2(a) of the WTO decision requires eligible importing Member countries to make a notification to the TRIPS Council recording certain information. (Note: the countries specified in Note 3 of the decision have already indicated that they will not use the compulsory licensing system as importing countries). 2.1 Are you aware - Whether your own country has filed a notification as an eligible importing Member country, and if so, when? Yes Date: Canada is a Member country listed in Note 3 of the decision indicating they will not use the compulsory licensing system as an importing country. 2.2 Whether any other country/countries have filed such a notification, and if so, which countries? Countries and dates: We are not aware of any specific notices to the TRIPS Council that contain the information required under clause 2(a) of the WTO decision. However, Bill C-9 does recognize this requirement, specifically, the amendment to the Patent Act to include s (3)(d). This section requires compliance with all of the terms in clause 2(a) before the Commissioner of Patents can authorize use of the patented invention. Bill C-9 also contains, in Schedules 2, 3 and 4, lists of eligible importing countries. To be listed in a Schedule a country must fulfil the requirements of s. 1 of the Act. Section 1 provides for the addition of s to the Patent Act. Before being added to a Schedule, a WTO Member country must have provided the TRIPS Council with a notice in writing stating that the country intends to import, in accordance with the General Council Decision, pharmaceutical products, as defined in paragraph 1(a) of that decision. Schedule 2, 3 and 4 the Act can be found at the website in answer
5 The notice for inclusion in a Schedule is a general notice and not the specific notice called for in both clause 2(a) of the WTO decision and s (3)(d) to be added to the Patent Act. 2.3 If your answer to 2.1 is Yes, are you aware of any compulsory licences granted in your country for the importation of pharmaceutical products, and if so, do you have any details as regard licensor, licensee, products covered, etc? Yes N/A 3. QUESTION 3 Granting, notification and information of export licences Clause 2(b) of the WTO decision deals with compulsory licences granted in exporting Member countries for the exportation of pharmaceutical products in terms of the waiver of TRIPS Art 31(f). 3.1 Are you aware of any compulsory licences which have been granted in your country for the exportation of pharmaceutical products to eligible importing member countries? If so, please provide details of which you are aware, such as licensor, licensee, products covered, etc. Yes No compulsory licences have been granted under the new legislation discussed in Question 1.1 above as the legislation has not yet been proclaimed into force. 3.2 Clause 2(c) of the WTO decision requires notification to the TRIPS Council by an exporting member country of the grant of any such compulsory licences. Are you aware of such a notification having been made, and if so, when? Yes Date(s): 5
6 The legislation in Canada is not yet in force. Therefore, there have been no opportunities to provide such notification. The Act does not include a specific requirement for notice to the TRIPS Council as called for in subparagraph 2(c) of the WTO General Council decision. 3.3 Clause 2(b) requires a licensee under such a compulsory licence to post certain information on a website. Are you aware of any such website? and if so, please provide details. Yes We are not aware of any such website and to-date none are required because there have been no compulsory licences issued. The Act in s. 1 amends the Patent Act to include s which requires a website to be created and the appropriate information posted before any exports can take place under an authorization granted by the Commissioner of Patents. 4. QUESTION 4 Prevention of re-exportation/diversion of imported products Clauses 4 and 5 of the WTO decision deal with the need to prevent reexportation of products imported into eligible importing countries under the licensing system. Are you aware 4.1 Whether special measures (in laws or otherwise) have been introduced in your country to prevent re-exportation of products? If so, please provide details, such as Government Act, Proclamation, export restriction, etc X Yes We are not aware of any special measures regarding re-export from Canada. Given that Canada is a non-importing country, such measures are not necessary in Canada itself. However, the Act amends the Patent Act to include s (f) and s (3)(b) which both act to prevent reexportation of products produced in Canada. Section 21.14(f) will allow the Federal Court, on application by the patentee, to terminate authorization where: 6
7 21.14(f) the product exported to the country or WTO Member, as the case may be, under the authorization has been, with the knowledge of the holder of the authorization, re-exported in a manner that is contrary to the General Council Decision. Section 21.04(3)(b) requires notification by the Minister of Health that the product meets the requirements of the Food and Drugs Act and its regulations, including: the requirements under those regulations relating to the marketing, embossing, labeling and packaging that identify that version of the product as having been manufactured (i) in Canada as permitted by the General Council Decision (ii) in a manner that distinguishes it from the version of the pharmaceutical product sold in Canada by, or with the consent of, the patentee or patentees, as the case may be 4.2 Whether any technical or financial cooperation or assistance has been provided to developing or least-developed countries to prevent trade diversion and re-exploitation? If so, please provide details, such as type of assistance, receiving country, etc. Yes We are not aware of any such assistance at this time. 5. QUESTION 5 Waiver of TRIPS Art 31(f): domestic market supply Clause 6 provides for the waiver of TRIPS Art 31(f), ie the restriction to use predominantly for the supply of the domestic market, in respect of developing and least-developed member countries which are parties to a regional trade agreement, to permit exportation to other parties of the regional trade agreement of products imported or manufactured under compulsory licences. Are you aware 7
8 5.1 In the event that your country falls within the provisions of Clause 6, whether use has been made of the exportation provisions of Clause 6? If so, please provide details. Yes N/A. Canada does not fall within the provisions of Clause In the event of exportation from your country in terms of a compulsory licence to a country/countries falling within the provisions of Clause 6, whether use has been made of the exportation provisions of Clause 6? If so, please provide details. Yes N/A 6. QUESTION 6 Technology transfer and capacity building Clause 7 provides for the promotion of technology transfer and capacity building in the pharmaceutical sector by using the compulsory licensing system of the WTO decision. Are you aware of any such technology transfer or capacity building initiatives, in your own country or elsewhere? If so, please provide details. Yes We are not aware of any such technology transfer or capacity building initiatives in Canada or elsewhere. Submitted on behalf of the Canadian Group by Steven B. Garland November 8,
Intellectual Property Laws Amendment Bill 2013 No., 2013
00-0-0-0 The Parliament of the Commonwealth of Australia HOUSE OF REPRESENTATIVES Presented and read a first time Intellectual Property Laws Amendment Bill 0 No., 0 (Industry, Innovation, Climate Change,
More informationIntellectual Property Laws Amendment Act 2015
Intellectual Property Laws Amendment Act 2015 No. 8, 2015 An Act to amend legislation relating to intellectual property, and for related purposes Note: An electronic version of this Act is available in
More informationUS-China Business Council Comments on the Draft Measures for the Compulsory Licensing of Patents
US-China Business Council Comments on the Draft Measures for the Compulsory Licensing of Patents The US-China Business Council (USCBC) and its member companies appreciate the opportunity to submit comments
More informationWIPO-ESCAP-IIUM Regional Workshop on Intellectual Property and Public Health and Environment Policy for Asia and Pacific
Intellectual Property and Public Health Cambodian Perspective WTO-ESCAP-IIUM REGIONAL WORKSHOP ON IP AND PUBLIC HEALTH AND ENVIRONMENT POLICY FOR ASIA AND PACIFIC REGION Kaula Lumpur, Malaysia 10-12 JULY
More informationTRIPS Article 28 Rights Conferred. 1. A patent shall confer on its owner the following exclusive rights:
TRIPS Article 28 Rights Conferred 1. A patent shall confer on its owner the following exclusive rights: (a) where the subject matter of a patent is a product, to prevent third parties not having the owner
More informationCRS Report for Congress
Order Code RS21609 Updated November 5, 2003 CRS Report for Congress Received through the CRS Web The WTO, Intellectual Property Rights, and the Access to Medicines Controversy Summary Ian F. Fergusson
More informationIMPLEMENTATION OF THE WTO DECISION ON COMPULSORY LICENSING FOR COUNTRIES WITH INSUFFICIENT OR NO MANUFACTURING CAPACITY IN THE PHARMACEUTICAL SECTOR
BRIEFING PAPER Policy Department External Policies IMPLEMENTATION OF THE WTO DECISION ON COMPULSORY LICENSING FOR COUNTRIES WITH INSUFFICIENT OR NO MANUFACTURING CAPACITY IN THE PHARMACEUTICAL SECTOR INTERNATIONAL
More informationFINAL PROPOSAL OF THE ACT ON AMENDMENTS TO THE PATENT ACT
FINAL PROPOSAL OF THE ACT ON AMENDMENTS TO THE PATENT ACT In the Patent Act ( Official Gazette Nos. 173/2003, 87/2005, 76/2007, 30/2009, 128/10 and 49/2011), after Article 1, Articles 1.a and 1.b are added
More informationAUSTRALIA Patents Act 1990 Compilation date: 24 February 2017 Includes amendments up to: Act No. 61, 2016 Registered: 27 February 2017
AUSTRALIA Patents Act 1990 Compilation date: 24 February 2017 Includes amendments up to: Act No. 61, 2016 Registered: 27 February 2017 TABLE OF CONTENTS Chapter 1. Introductory 1 Short title 2 Commencement
More informationEarly Resolution Mechanism for Patent Disputes Regarding Approved Drug Products - Canada
Early Resolution Mechanism for Patent Disputes Regarding Approved Drug Products - Canada Pharma Workshop 4 AIPPI Toronto September 16, 2014 Warren Sprigings Direct Dial: +1-416-777-2273 warren@sprigings.com
More informationDenmark and Italy Trade-related intellectual property rights, access to medicines and human rights
Summary Denmark and Italy Trade-related intellectual property rights, access to medicines and human rights October 2004 1. Denmark and Italy, as members of the European Union (EU), have committed themselves
More informationIntellectual Property Department Hong Kong, China. Contents
Intellectual Property Department Hong Kong, China Contents Section 1: General... 1 Section 2: Private and/or non-commercial use... 3 Section 3: Experimental use and/or scientific research... 3 Section
More informationA I P P I ASSOCIATION INTERNATIONALE POUR LA PROTECTION DE LA PROPRIETE INTELLECTUELLE
A I P P I ASSOCIATION INTERNATIONALE POUR LA PROTECTION DE LA PROPRIETE INTELLECTUELLE INTERNATIONAL ASSOCIATION FOR THE PROTECTION OF INTELLECTUAL PROPERTY INTERNATIONALE VEREINIGUNG FÜR DEN SCHUTZ DES
More informationOFFICIAL GAZETTE OF THE REPUBLIC OF KOSOVA / No. 12 / 29 AVGUST 2011, PRISTINA. LAW No. 04/L-029 ON PATENTS LAW ON PATENTS
OFFICIAL GAZETTE OF THE REPUBLIC OF KOSOVA / No. 12 / 29 AVGUST 2011, PRISTINA LAW No. 04/L-029 ON PATENTS Assembly of Republic of Kosovo; Based on Article 65 (1) of the Constitution of the Republic of
More informationRegional Group Central America and the Caribbean
Question Q241 National Group: Title: Contributors: Reporter within Working Committee: Regional Group Central America and the Caribbean IP licensing and insolvency Leticia CAMINERO Dominican Republic (Green)
More informationCompilation date: 24 February Includes amendments up to: Act No. 61, Registered: 27 February 2017
Patents Act 1990 No. 83, 1990 Compilation No. 41 Compilation date: 24 February 2017 Includes amendments up to: Act No. 61, 2016 Registered: 27 February 2017 This compilation includes commenced amendments
More information[English translation by WIPO] Questionnaire on Exceptions and Limitations to Patent Rights
Questionnaire on Exceptions and Limitations to Patent Rights The answers to this questionnaire have been provided on behalf of: Country: Chile... Office: National Institute of Industrial Property (INAPI)...
More informationThe Patents (Amendment) Act,
!"# The Patents (Amendment) Act, 2005 1 [NO. 15 OF 2005] CONTENTS [April 4, 2005] Sections Sections 1. Short title and commencement 40. Amendment of Section 57 2. Amendment of Section 2 41. Substitution
More information: Liability for contributory infringement of IPRs certain aspects of patent infringement
Question Q204P National Group : AIPPI Indonesia Title : Liability for contributory infringement of IPRs certain aspects of patent infringement Contributors : Migni Myriasandra Representative within Working
More informationNotwithstanding Article 29, any invention that is liable to injure public order, morality or public health shall not be patented (Article 32).
Japan Patent Office (JPO) Contents Section 1: General... 1 Section 2: Private and/or non-commercial use... 2 Section 3: Experimental use and/or scientific research... 3 Section 4: Preparation of medicines...
More informationQuestionnaire on Exceptions and Limitations to Patent Rights. The answers to this questionnaire have been provided on behalf of:
The answers to this questionnaire have been provided on behalf of: Country: Office: Bhutan Intellectual Property Division, Ministry of Economic Affairs, Thimphu Person to be contacted: Name: Mr. Sonam
More informationQuestionnaire on Exceptions and Limitations to Patent Rights. The answers to this questionnaire have been provided on behalf of:
Questionnaire on Exceptions and Limitations to Patent Rights The answers to this questionnaire have been provided on behalf of: Country: Australia... Office: IP Australia... Person to be contacted: Name:
More informationT H E W O R L D J O U R N A L O N J U R I S T I C P O L I T Y. BOLAR EXEMPTION VS. DATA EXCLUSIVITY: RIGHT TO HEALTH vs RIGHT OF PATENT HOLDER
BOLAR EXEMPTION VS. DATA EXCLUSIVITY: RIGHT TO HEALTH vs RIGHT OF PATENT HOLDER Rhea Roy Mammen M.S. Ramaiah College of Law, Bangalore Introduction Pharmaceutical Patent has seen an increasing conflict
More informationTrade-related intellectual property rights, trade in services and the fulfilment of children s rights - Botswana September 2004
Trade-related intellectual property rights, trade in services and the fulfilment of children s rights - Botswana September 2004 Introduction 1. Botswana has emerged as a model of access to medicines and
More informationBE it enacted by Parliament in the Fifty-sixth Year of the Republic of India as follows:-
~ THE PATENTS (AMENDMENT) ACT, 2005 # NO. 15 OF 2005 $ [4th April, 2005] + An Act further to amend the Patents Act, 1970. BE it enacted by Parliament in the Fifty-sixth Year of the Republic of India as
More informationComments on Discussion Paper on Compulsory Licensing
Comments on Discussion Paper on Compulsory Licensing Indian Pharmaceutical Alliance 25 September 2010 1 Contents Issue Page No Preface 3 1 Are guidelines necessary for issue of compulsory licences? 4 2
More informationPlease number your answers with the same numbers used for the corresponding questions.
Question Q241 National Group: Title: Contributors: Reporter within Working Committee: The Latvian National Group IP licensing and insolvency Vadim MANTROV Vadim MANTROV Date: 19 May 2014 Questions I. Current
More informationTHE PATENT LAW 1 I INTRODUCTORY PROVISIONS. 1. Subject Matter of Regulation and Definitions. Subject Matter of Regulation.
THE PATENT LAW 1 I INTRODUCTORY PROVISIONS 1. Subject Matter of Regulation and Definitions Subject Matter of Regulation Article 1 This Law shall regulate the legal protection of inventions. The invention
More information(In text and on CD-ROM) 1 Some Premises and Commentary... 1 Form 1.01 Construction... 13
Contents of Forms (In text and on CD-ROM) 1 Some Premises and Commentary... 1 Form 1.01 Construction... 13 2 Legal Principles... 15 Form 2.01 Definition of Licensed Information... 18 Form 2.02 Assignment
More informationTHE ISSUE OF BALANCING RIGHTS IN THE PATENT PROTECTION
THE ISSUE OF BALANCING RIGHTS IN THE PATENT PROTECTION FINAL REPORT JPO FUND RESEARCH FELLOWSHIP PROGRAM 01 October, 2002 29 March, 2003 Prepared by: TA QUANG MINH VIETNAM TOKYO February, 2003 TABLE OF
More informationMODULE. Conclusion. ESTIMATED TIME: 3 hours
MODULE 11 Conclusion ESTIMATED TIME: 3 hours 1 Overview I. MODULE 1 INTRODUCTION TO THE WTO SUMMARY... 3 II. MODULE 2 INTRODUCTION TO THE TRIPS AGREEMENT SUMMARY... 5 III. MODULE 3 COPYRIGHT AND RELATED
More informationPatent Act, B.E (1979) As Amended until Patent Act (No.3), B.E (1999) Translation
Patent Act, B.E. 2522 (1979) As Amended until Patent Act (No.3), B.E. 2542 (1999) Translation BHUMIBOL ADULYADEJ, REX. Given on the 11th day of March, B.E. 2522; Being the 34th year of the present Reign
More informationQuestionnaire Apotex Inc. v Sanofi-Aventis Proposed AIPPI intervention Supreme Court of Canada appeal
National Group: Hungarian Title: Reporter: Contributors: Questionnaire Apotex Inc. v Sanofi-Aventis Proposed AIPPI intervention Supreme Court of Canada appeal Dr. PETHŐ, Árpád Dr. PETHŐ, Árpád, MOLNÁR,
More informationThe Third Amendment to the Patent Law of China. On December 27, 2008, the Standing Committee of the National People's
The Third Amendment to the Patent Law of China On December 27, 2008, the Standing Committee of the National People's Congress adopted the third amendment to the Patent Law of the People's Republic of China,
More informationDate: 22 August Packaging Questionnaire. Questions
National Group: ESTONIA Contributors: Mari MUST Date: 22 August 2013 Packaging Questionnaire Questions Please answer the following questions. For each of questions 1) 10) below, please answer in relation
More informationExclusions from patentability 15 Inventions contrary to public order or morality not patentable
New Zealand Patents Act 2013 Public Act 2013 No 68 Date of assent 13 September 2013 Reprint as at 14 September 2017 TABLE OF CONTENTS 1 Title 2 Commencement Part 1 Preliminary Purposes and overview 3 Purposes
More informationInformal Brief. The Treatment Of Intellectual Property In The Ministerial Declaration: Mandated Negotiations And Reviews
Informal Brief The Treatment Of Intellectual Property In The Ministerial Declaration: Mandated Negotiations And Reviews By David Vivas Eugui Senior Attorney, Center for International Environmental Law
More information4. COMPARISON OF THE INDIAN PATENT LAW WITH THE PATENT LAWS IN U.S., EUROPE AND CHINA
4. COMPARISON OF THE INDIAN PATENT LAW WITH THE PATENT LAWS IN U.S., EUROPE AND CHINA Provisions of the Indian patent law were compared with the relevant provisions of the patent laws in U.S., Europe and
More informationPATENT ACT, B.E (1979) 1. BHUMIBOL ADULYADEJ, REX; Given on the 11 th Day of March B.E. 2522; Being the 34 th Year of the Present Reign
Unofficial Translation PATENT ACT, B.E. 2522 (1979) 1 BHUMIBOL ADULYADEJ, REX; Given on the 11 th Day of March B.E. 2522; Being the 34 th Year of the Present Reign His Majesty King Bhumibol Adulyadej is
More informationLaw on the protection of inventions No. 50/2008 of the Republic of Moldova can be found at:
The answers to this questionnaire have been provided on behalf of: Country: Republic of Moldova... Office: The State Agency on Intellectual Property... Person to be contacted: Name: Cicinova Olga... Title:
More informationPeople s Republic of China State Intellectual Property Office of China
[English translation by WIPO] Questionnaire on Exceptions and Limitations to Patent Rights The answers to this questionnaire have been provided on behalf of: Country: Office: People s Republic of China
More informationGEM handy dandy Technical Committees Patents Guide 4/14/99
GEM handy dandy Technical Committees Patents Guide 4/14/99 Meeting call for patents: Technical Committees and/or Technical Committee Task Groups and their ad hocs (working groups) should make regular calls
More informationANNEX XV REFERRED TO IN ARTICLE 7 PROTECTION OF INTELLECTUAL PROPERTY
ANNEX XV REFERRED TO IN ARTICLE 7 PROTECTION OF INTELLECTUAL PROPERTY ANNEX XV REFERRED TO IN ARTICLE 7 PROTECTION OF INTELLECTUAL PROPERTY SECTION I GENERAL PROVISIONS Article 1 Definition of Intellectual
More informationINTERNATIONAL COURT OF ARBITRATION NEW DELHI, INDIA GOOD HEALTH COMPANY CLAIMANT DIRECTOR OF INTELLECTUAL PROPERTY, STATE OF MARU RESPONDENT
INTERNATIONAL COURT OF ARBITRATION NEW DELHI, INDIA 2010 GOOD HEALTH COMPANY CLAIMANT v. DIRECTOR OF INTELLECTUAL PROPERTY, STATE OF MARU RESPONDENT MEMORIAL FOR THE RESPONDENT TABLE OF CONTENTS TABLE
More informationHuman Rights and Development. Joel P. Trachtman The Fletcher School of Law and Diplomacy
Trade, Investment, Human Rights and Development Joel P. Trachtman The Fletcher School of Law and Diplomacy Tufts University The Backlash Against Globalization Trump Brexit Developing countries? Trade,
More informationSecond medical use or indication claims. Mr. Antonio Ray ORTIGUERA Angara Abello Concepcion Regala & Cruz Law Offices Philippines
Question Q238 National Group: Title: Contributors: Reporter within Working Committee: PHILIPPINES Second medical use or indication claims Mr. Alex Ferdinand FIDER Mr. Antonio Ray ORTIGUERA Angara Abello
More informationThe methods and procedures described must be directly applicable to production.
National Patent Administration Argentina Contents Section 1: General... 1 Section 2: Private and/or non-commercial use... 3 Section 3: Experimental use and/or scientific research... 3 Section 4: Preparation
More informationFrom Law of Patents, Layout Designs of Integrated Circuits, Plant Varieties, and Industrial Designs, Chapter Two:
Saudi Patent Office Contents Section 1: General... 1 Section 2: Private and/or non-commercial use... 2 Section 3: Experimental use and/or scientific research... 3 Section 4: Preparation of medicines...
More informationProposal for a COUNCIL DECISION
EUROPEAN COMMISSION Brussels, 10.9.2015 COM(2015) 426 final 2015/0190 (NLE) Proposal for a COUNCIL DECISION establishing the position to be taken on behalf of the European Union within the Council for
More informationQuestionnaire on Exceptions and Limitations to Patent Rights. The answers to this questionnaire have been provided on behalf of:
The answers to this questionnaire have been provided on behalf of: Country: Office: Republic of Poland Patent Office of the Republic of Poland Person to be contacted: Name: Piotr Czaplicki Title: Director,
More informationSouth-South Exchanges related to Patents in Developing Countries and LDCs: A Civil Society Reading
South-South Exchanges related to Patents in Developing Countries and LDCs: A Civil Society Reading Heba Wanis BSc, MPH Researcher Egyptian Initiative for Personal Rights Second WIPO Inter-Regional Meeting
More informationAttachment: Opinions on the Draft Amendment of the Implementing Regulations of the Patent Law of the People s Republic of China
March 31, 2009 To: Legislative Affairs Office State Council People s Republic of China Hirohiko Usui President Japan Intellectual Property Association Opinions on the Draft Amendment of the Implementing
More informationSecond medical use or indication claims. [Please insert name last name in CAPITAL letters please]
Question Q238 National Group: Title: Contributors: Reporter within Working Committee: New Zealand Second medical use or indication claims Michael BROWN, Partner Helen BELLCHAMBERS, Associate A J Park [Please
More informationAnti-counterfeiting laws and access to essential medicines in East and Southern Africa
Regional Network for Equity in Health in East and Southern Africa (EQUINET) Anti-counterfeiting laws and access to essential medicines in East and Southern Africa EQUINET Policy Brief number 22 Co-published
More informationAnnex III. General Terms and Conditions
Annex III General Terms and Conditions 1. ACCEPTANCE OF THE PURCHASE ORDER This Purchase Order may only be accepted by the Supplier's signing and returning an acknowledgement copy of it or by timely delivery
More informationCOMPULSORY LICENCE in Germany. Markus Rieck LL.M.
COMPULSORY LICENCE in Germany Markus Rieck LL.M. 1 1877 - GERMAN PATENT ACT Bundesarchiv, Bild 183-R68588 / P. Loescher & Petsch / CC-BY-SA 3.0 2 Public interest Dependent patent Plant breeders privilege*
More informationEconomic Damages in IP Litigation
Economic Damages in IP Litigation September 22, 2016 HCBA, Intellectual Property Section Steven S. Oscher, CPA /ABV/CFF, CFE Oscher Consulting, P.A. Lost Profits Reasonable Royalty * Patent Utility X X
More informationPatent Litigation. Block 2; Module Plaintiff /Claimant. Essentials. The patent proprietor as plaintiff/claimant in infringement proceedings
Patent litigation. Block 2. Module Essentials The patent proprietor as plaintiff/claimant in infringement proceedings In a patent infringement action and/or any other protective measure, the plaintiff/claimant
More informationTRIPS, from the WTO to. Presented by: Catherine Mateu
TRIPS, from the WTO to businesses Presented by: Catherine Mateu 1 Partner at Armengaud Guerlain Chair of the TRIPS Standing Committee (AIPPI) www.aippi.org Fluent in French, Spanish, English, and Basque
More informationQuestionnaire on Exceptions and Limitations to Patent Rights. The answers to this questionnaire have been provided on behalf of:
The answers to this questionnaire have been provided on behalf of: Country: Austria... Office: Austrian Patent Office (APO)... Person to be contacted: Name:... Title:... E-mail:... Telephone:... Facsimile:...
More information[English translation by WIPO] Questionnaire on Exceptions and Limitations to Patent Rights
[English translation by WIPO] Questionnaire on Exceptions and Limitations to Patent Rights The answers to this questionnaire have been provided on behalf of: Country: Office: Dominican Republic... National
More informationA I P P I ASSOCIATION INTERNATIONALE POUR LA PROTECTION DE LA PROPRIETE INTELLECTUELLE
A I P P I ASSOCIATION INTERNATIONALE POUR LA PROTECTION DE LA PROPRIETE INTELLECTUELLE INTERNATIONAL ASSOCIATION FOR THE PROTECTION OF INTELLECTUAL PROPERTY INTERNATIONALE VEREINIGUNG FÜR DEN SCHUTZ DES
More informationGeneral Terms and Conditions for Goods 1. ACCEPTANCE OF THE PURCHASE ORDER This Purchase Order may only be accepted by the Supplier's signing and returning an acknowledgement copy of it or by timely delivery
More informationIntegrated Circuit Topography Act*
Integrated Circuit Topography Act* (1990, c. 37 amended by S.C. 1992, c. 1; 1993, c. 15; 1994, c. 47; 1995, c. 1) TABLE OF CONTENTS** Sections Short Title Short Title... 1 Interpretation Definitions...
More informationHUNGARY Patent Act Act XXXIII of 1995 as consolidated on March 01, 2015
HUNGARY Patent Act Act XXXIII of 1995 as consolidated on March 01, 2015 TABLE OF CONTENTS PART I INVENTIONS AND PATENTS Chapter I SUBJECT MATTER OF PATENT PROTECTION Article 1 Patentable inventions Article
More information1. The following prime contract special provisions apply to this purchase order:
Page 1of 12 CUSTOMER CONTRACT REQUIREMENTS Topic 2 Rotorcraft Durability; High Performance, Low Vibration and Low Noise Enabling Technology Program CUSTOMER CONTRACT W911W6-08-2-0003 CUSTOMER CONTRACT
More informationStanding Committee on Patents. Questionnaire on the Publication of Patent Applications India Section
Standing Committee on Patents Questionnaire on the Publication of Patent Applications India Section I. Analysis of current law and case law 1. Please provide a brief description of your law concerning
More informationWORKSHOP 1: IP INFRINGEMENT AND INTERNATIONAL FORUM SHOPPING
43 rd World Intellectual Property Congress Seoul, Korea WORKSHOP 1: IP INFRINGEMENT AND INTERNATIONAL FORUM SHOPPING October 21, 2012 John Kim* Admitted to practice in Maryland, the District of Columbia,
More information[English translation by WIPO] Questionnaire on Exceptions and Limitations to Patent Rights
[English translation by WIPO] Questionnaire on Exceptions and Limitations to Patent Rights The answers to this questionnaire have been provided on behalf of: Country: Office: EL SALVADOR... National Registration
More informationhaving regard to the Commission proposal to Parliament and the Council (COM(2013)0161),
P7_TA-PROV(2014)0118 Community trade mark ***I European Parliament legislative resolution of 25 February 2014 on the proposal for a regulation of the European Parliament and of the Council amending Council
More informationCANCUN SESSION OF THE PARLIAMENTARY CONFERENCE ON THE WTO Cancún (Mexico), 9 and 12 September 2003
CANCUN SESSION OF THE PARLIAMENTARY CONFERENCE ON THE WTO Cancún (Mexico), 9 and 12 September 2003 Organised jointly by the Inter-Parliamentary Union and the European Parliament with the support of the
More informationThailand. Alan Adcock, Clemence Gautier, and Areeya Pornwiriyangkura Tilleke & Gibbins International Ltd Bangkok, Thailand
Alan Adcock, Clemence Gautier, and Areeya Pornwiriyangkura Tilleke & Gibbins International Ltd Bangkok, Thailand Nature of Licence Agreements Definition A licence agreement is simply a contract that governs
More informationPOVERTY, TRADE AND HEALTH: AN EMERGING HEALTH DEVELOPMENT ISSUE. Report of the Regional Director EXECUTIVE SUMMARY
17 June 2006 REGIONAL COMMITTEE FOR AFRICA ORIGINAL: ENGLISH Fifty-sixth session Addis Ababa, Ethiopia, 28 August 1 September 2006 Provisional agenda item 8.3 POVERTY, TRADE AND HEALTH: AN EMERGING HEALTH
More informationWORLD TRADE ORGANIZATION
WORLD TRADE ORGANIZATION Council for Trade-Related Aspects of Intellectual Property Rights IP/C/W/424/Add.2 26 October 2004 (04-4530) Original: English TECHNICAL COOPERATION ACTIVITIES: INFORMATION FROM
More informationPatentable Subject Matter and Medical Use Claims in the Pharmaceutical Sector
Patentable Subject Matter and Medical Use Claims in the Pharmaceutical Sector 2012 LIDC Congress, Prague, 12 October 2012 Dr. Simon Holzer, Attorney-at-Law, Partner 3 October 2012 2 Introduction! Conflicting
More informationDelegations will find in the Annex a Presidency compromise proposal concerning the abovementioned
COUNCIL OF THE EUROPEAN UNION Brussels, 20 February 2014 (OR. en) 6570/14 Interinstitutional File: 2013/0088 (COD) PI 20 CODEC 433 NOTE From: To: General Secretariat of the Council Delegations No. Cion
More informationNote: When any ambiguity of interpretation is found in this provisional translation, the Japanese text shall prevail.
Note: When any ambiguity of interpretation is found in this provisional translation, the Japanese text shall prevail. (Applied to any applications to register a patent term extension filed on or after
More informationRegional Seminar for Certain African Countries on the Implementation and Use of Several Patent-Related Flexibilities
REPUBLIC OF SOUTH AFRICA Regional Seminar for Certain African Countries on the Implementation and Use of Several Patent-Related Flexibilities Topic 13: The Effective Administrative Process for the Grant
More informationThe National Center of Intellectual Property Belarus. Contents
The National Center of Intellectual Property Belarus Contents Section 1: General... 1 Section 2: Private and/or non-commercial use... 3 Section 3: Experimental use and/or scientific research... 4 Section
More informationDrafting Patent License Agreements Course Syllabus
I. SOME PREMISES, LIMITATIONS, AND LEGAL PRINCIPLES A. Orientation and a Disclaimer of Legal Completeness B. Evaluating the Legal Nature of the Subject Matter 1. The Scope of a Patent 2. The Scope of Unpatented
More informationTime allowed : 3 hours Maximum marks : 100. Total number of questions : 6 Total number of printed pages : 8
OPEN BOOK EXAMINATION Roll No... : 1 : 344 Time allowed : 3 hours Maximum marks : 100 Total number of questions : 6 Total number of printed pages : 8 NOTE : Answer ALL Questions. 1. Read the following
More informationCONSOLIDATED TEXT REFLECTS CHANGES MADE DURING THE SEPTEMBER 2010 TOKYO ROUND. Consolidated Text. Anti-Counterfeiting Trade Agreement
CONSOLIDATED TEXT REFLECTS CHANGES MADE DURING THE SEPTEMBER 2010 TOKYO ROUND Consolidated Text Anti-Counterfeiting Trade Agreement Informal Predecisional/Deliberative Draft: 2 October 2010 This text reflects
More informationSWITZERLAND: Patent Litigation CHAMBERS 2017 DOING BUSINESS IN BRAZIL: Global Practice Guides. Switzerland LAW & PRACTICE: p.<?> p.3. p.<?> p.
CHAMBERS SWITZERLAND AUSTRIA BRAZIL Patent Litigation Global Practice Guides LAW & PRACTICE: Switzerland p. p.3 Contributed by Fialdini Pestalozzi Einsfeld Advogados Contributed by Pestalozzi The Law
More informationPatent Enforcement in India
Patent Enforcement in India Intellectual property assets are touted as the cornerstone of competitiveness in international trade and are the driving factors behind socio-economic development in India.
More informationClaims and Determining Scope of Protection
Introduction 2014 APAA Patents Committee Questionnaire Claims and Determining Scope of Protection for Taiwan Group Many practitioners and users of the patent system believe that it is a fairly universal
More informationEffect of TRIPS on Pricing, Affordability and Access to Essential Medicines in Bhutan
Effect of TRIPS on Pricing, Affordability and Access to Essential Medicines in Bhutan Abstract DR. TANDI DORJI ** Health care in Bhutan is free and the Essential Drugs Program under the Ministry of Health
More information2018 Bill. Fourth Session, 29th Legislature, 67 Elizabeth II THE LEGISLATIVE ASSEMBLY OF ALBERTA BILL 6
2018 Bill Fourth Session, 29th Legislature, 67 Elizabeth II THE LEGISLATIVE ASSEMBLY OF ALBERTA BILL 6 GAMING AND LIQUOR STATUTES AMENDMENT ACT, 2018 THE MINISTER OF JUSTICE AND SOLICITOR GENERAL First
More informationQuestionnaire on Exceptions and Limitations to Patent Rights
Questionnaire on Exceptions and Limitations to Patent Rights The answers to this questionnaire have been provided on behalf of: Country: Office: India The Patent Office Person to be contacted: Name: Dr
More informationProposal for a COUNCIL DECISION
EUROPEAN COMMISSION Brussels, 24.6.2011 COM(2011) 380 final 2011/0167 (NLE) Proposal for a COUNCIL DECISION on the conclusion of the Anti-Counterfeiting Trade Agreement between the European Union and its
More informationCANADA Industrial Design Act as amended by c. 34 of 2001 Current to October 31, 2012
CANADA Industrial Design Act as amended by c. 34 of 2001 Current to October 31, 2012 TABLE OF CONTENTS SHORT TITLE 1. Short title INTERPRETATION 2. Definitions PART I INDUSTRIAL DESIGNS Registration 3.
More informationThe requirement of genuine use of trademarks for maintaining protection
Question Q218 National Group: The Philippines Title: Contributors: The requirement of genuine use of trademarks for maintaining protection Aleli Angela G. Quirino John Paul M. Gaba May A. Caniba-Llona
More information[English translation by WIPO] Questionnaire on Exceptions and Limitations to Patent Rights. Name:... Title: Telephone:... Facsimile:...
[English translation by WIPO] Questionnaire on Exceptions and Limitations to Patent Rights The answers to this questionnaire have been provided on behalf of: Country: Office: Burkina Faso National Directorate
More informationInt l IP. Module 3 Patent Law
Int l IP Module 3 Patent Law 3-1 The elements of Patentability Patentable subject matter, i.e., patent eligibility Useful/utility (operable and provides a tangible benefit) New (statutory bar, novelty,
More informationNIGERIA Patents and Designs Act Chapter 344, December 1, 1971 Laws of the Federation of Nigeria 1990
NIGERIA Patents and Designs Act Chapter 344, December 1, 1971 Laws of the Federation of Nigeria 1990 TABLE OF CONTENTS Patents 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. Designs 12. 13. 14. 15. 16. 17. 18. 19.
More informationRESPONSE TO. Questionnaire. On the patent system in Europe INTRODUCTION
RESPONSE TO Questionnaire On the patent system in Europe INTRODUCTION PRIVACY STATEMENT I do consent to the publication of my personal data or data relating to my organisation with the publication of my
More informationThe Patented Medicines (Notice of Compliance) Regulations: What patents are eligible to be listed on the register?
The Patented Medicines (Notice of Compliance) Regulations: What patents are eligible to be listed on the register? Edward Hore Hazzard & Hore 141 Adelaide Street West, Suite 1002 Toronto, ON M5H 3L5 (416)
More informationGlobal Access to Medicines Program Compiled by Stephanie Rosenberg. December 2, This chart compares provisions from the following texts:
Comparative chart of patent and data provisions in the TRIPS, Free Trade s between Trans-Pacific negotiating countries and the U.S., and the U.S. proposal to the Trans-Pacific This chart compares provisions
More informationFINAL REPORT THE PATENTS AND DESIGNS ACT, INTRODUCTION PATENTS
FINAL REPORT ON THE PATENTS AND DESIGNS ACT, 200----- INTRODUCTION PATENTS In England grants of monopoly rights to exploit an invention by the inventor date back to the Elizabethan (Queen Elizabeth I)
More informationTHE IMPLICATIONS OF RWANDA S PARAGRAPH 6 AGREEMENT
THE IMPLICATIONS OF RWANDA S PARAGRAPH 6 AGREEMENT WITH CANADA FOR OTHER DEVELOPING COUNTRIES Christina Cotter I. Introduction On July 17, 2007, Rwanda became the first country to notify the World Trade
More informationThe Principle of Integration in WTO/TRIPS Jurisprudence Henning Grosse Ruse - Khan
Max Planck Institute for Intellectual Property and Competition Law The Principle of Integration in WTO/TRIPS Jurisprudence Henning Grosse Ruse - Khan Sustainable Development Principles in the Decisions
More information